SSRI Ineffective at Treating Depression in Individuals with Chronic Kidney Disease
Dr. Madhukar Trivedi and colleagues find the SSRI sertraline does not reduce depression more than placebo in people with Chronic Kidney Disease
Stay updated with breaking news from Antidepressant Effectiveness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr. Madhukar Trivedi and colleagues find the SSRI sertraline does not reduce depression more than placebo in people with Chronic Kidney Disease
Regulators approve drugs despite contradictory trial results, and let drugs onto the market that do not provide tangible clinical benefits.
Researchers find that Antidepressants double the risk of suicide in youth, and the risk for adults may have been seriously underestimated.
Researchers found no evidence of antidepressant group variance: there's no particular group of patients who improve more than others.
Surveyed doctors overestimate pharmacological effects of antidepressants and underestimate placebo effects